Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing.
van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Tibben A. van Oostrom I, et al. Among authors: van asperen cj, van gool ar. Ann Oncol. 2006 Jul;17(7):1090-5. doi: 10.1093/annonc/mdl069. Epub 2006 Apr 6. Ann Oncol. 2006. PMID: 16600981 Free article.
Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.
Heemskerk-Gerritsen BA, Seynaeve C, van Asperen CJ, Ausems MG, Collée JM, van Doorn HC, Gomez Garcia EB, Kets CM, van Leeuwen FE, Meijers-Heijboer HE, Mourits MJ, van Os TA, Vasen HF, Verhoef S, Rookus MA, Hooning MJ; Hereditary Breast and Ovarian Cancer Research Group Netherlands. Heemskerk-Gerritsen BA, et al. Among authors: van asperen cj, van doorn hc, van os ta, van leeuwen fe. J Natl Cancer Inst. 2015 Mar 18;107(5):djv033. doi: 10.1093/jnci/djv033. Print 2015 May. J Natl Cancer Inst. 2015. PMID: 25788320
Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.
de Bock GH, Mourits MJ, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG. de Bock GH, et al. Among authors: van asperen cj. Int J Gynecol Cancer. 2006;16 Suppl 2:552-5. doi: 10.1111/j.1525-1438.2006.00694.x. Int J Gynecol Cancer. 2006. PMID: 17010071
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations.
Brohet RM, Velthuizen ME, Hogervorst FB, Meijers-Heijboer HE, Seynaeve C, Collée MJ, Verhoef S, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gómez García E, Menko F, Oosterwijk JC, Devilee P, van't Veer LJ, van Leeuwen FE, Easton DF, Rookus MA, Antoniou AC; HEBON Resource. Brohet RM, et al. Among authors: van asperen cj, van t veer lj, van leeuwen fe. J Med Genet. 2014 Feb;51(2):98-107. doi: 10.1136/jmedgenet-2013-101974. Epub 2013 Nov 27. J Med Genet. 2014. PMID: 24285858
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study.
Wevers MR, Schmidt MK, Engelhardt EG, Verhoef S, Hooning MJ, Kriege M, Seynaeve C, Collée M, van Asperen CJ, Tollenaar RA, Koppert LB, Witkamp AJ, Rutgers EJ, Aaronson NK, Rookus MA, Ausems MG. Wevers MR, et al. Among authors: van asperen cj. Fam Cancer. 2015 Sep;14(3):355-63. doi: 10.1007/s10689-015-9788-x. Fam Cancer. 2015. PMID: 25700605 Free PMC article.
218 results